Respironics ( RESP ) is RMD only competitor in the APNEA disorder arena . Both control 99% of the world market . A new ( ALLEGEDLY ) entrant has been named about 6 months ago . As foreshadowed at the time , the entrant was the excuse the market used to mark RMD down from its high valuation . Period . Current weakness stemmed from general bad sentiment in the USA ( RMD is primarily an American stock ) equities markets , its past hi valuation ( not anymore though ) and a recent change in the German PBS and the recent appreciation of the A$ v US$ . RMD is the technological leader in this field . No one is even closer to its high standard . It is the "TRINTRON" of the apnea market !
RMD will kick back big time IMHO . It is only a matter of time . Duff
Resmed, page-10
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$30.60 |
Change
-0.670(2.14%) |
Mkt cap ! $19.39B | |||
| Open | High | Low | Value | Volume |
| $30.37 | $30.64 | $30.12 | $86.17M | 2.818M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 327 | $30.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $30.63 | 57 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |